Skip to content
Back to Investors
NE

North East Innovation Fund

Government

The North East Fund is a suite of five venture capital and loan funds established to invest in small and medium-sized enterprises.

Portfolio

6

companies

By category

  • MedTech£3.8M
  • Enterprise Software£2.6M
  • FinTech£1.7M
  • SaaS£750K
  • SecurTech£600K
  • Other£250K

By location

  • Newcastle upon Tyne£8.1M
  • United Kingdom£750K
  • Northeast India£600K
  • Durham£250K

Portfolio companies

Hicomply

Hicomply

Hicomply provides a software platform that automates information security compliance for small and medium enterprises.

Magnitude Biosciences

Magnitude Biosciences

Magnitude Biosciences provides nematode worm testing services to accelerate preclinical drug discovery for biotech firms.

MN

Manus Neurodynamica

Manus Neurodynamica develops diagnostic technology for neuromotor disorders.

OE

Oak Engage

Oak Engage provides an employee engagement and intranet SaaS platform for enterprise clients.

O

OnHand

A social impact platform enabling businesses to coordinate employee volunteering and sustainability initiatives.

One Utility Bill

One Utility Bill

Simplifying household utilities and billing administration for tenants and landlords.


Recent investments

£750K

Northstar Ventures led the funding round, with participation from 24 Haymarket.

"It’s no surprise that OnHand is thriving, thanks to their exceptional leadership team. Our investment will support technical improvements to enhance the platform’s gamification and expand user options even further. It will also help the company achieve their ambition of breaking into the enterprise market. We are thrilled to support such an exciting, innovative company, as we recognise the value of corporate volunteering."
— Naomi Allen Seales, Investment Manager
£2.6M

Northstar Ventures and Par Equity co-led the investment round to support international expansion and US regulatory clearance.

"I’d like to thank Manus’ existing investors for supporting the Company’s commercialisation programme of our unique NeuroMotor PenTM , building on previous support we received in 2021. This year is set to be an exciting one, with partnerships already secured, and we truly believe our non-invasive and CE-marked product can have a huge impact on patients and tackle the unmet need for a quick, inexpensive device that can detect neurological conditions, particularly given the ageing global population."
— Rutger Zietsma, CEO
Series A
£2.6M

Maven Capital Partners led the Series A follow on round with participation from regional funds and private investors to scale operations and expand the team.

"Oak is a proven, fast growing technology business led by strong, experienced management team. The platform is globally scalable and as employee engagement is becoming increasingly recognised as pivotal in the overall success of a business, Oak continues to secure a number of impressive customer contacts. We look forward to working with Will and the team as the company scales further and continues to expand."
— Michael Vassallo, Investment Partner